Phillip Chan | executive |
Kathleen Bloch | executive |
Efthymios Deliargyris | executive |
Yuan Zhi | analyst |
Xun Lee | analyst |
Christian Steiner | executive |
Thomas Kerr | analyst |
Vincent Capponi | executive |
Good afternoon, and welcome to Cytosorbents' First Quarter 2024 Financial and Operating Results Conference Call. [Operator Instructions] Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company's request. At this time, I'd like to turn the call over to our moderator, Eric Ribner. Please go ahead, Mr. Ribner.